chr7-146116535-A-AT

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BS1_Supporting

The ENST00000625365.2(CNTNAP2):​c.-229-102dup variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0106 in 230,030 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0013 ( 0 hom., cov: 31)
Exomes 𝑓: 0.026 ( 0 hom. )

Consequence

CNTNAP2
ENST00000625365.2 intron

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, single submitter U:2

Conservation

PhyloP100: -0.132
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.0262 (2256/86082) while in subpopulation MID AF= 0.0347 (14/404). AF 95% confidence interval is 0.0256. There are 0 homozygotes in gnomad4_exome. There are 1163 alleles in male gnomad4_exome subpopulation. Median coverage is 0. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CNTNAP2ENST00000625365.2 linkuse as main transcriptc.-229-102dup intron_variant 5

Frequencies

GnomAD3 genomes
AF:
0.00120
AC:
173
AN:
143886
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00264
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00185
Gnomad SAS
AF:
0.000661
Gnomad FIN
AF:
0.000688
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000428
Gnomad OTH
AF:
0.00201
GnomAD4 exome
AF:
0.0262
AC:
2256
AN:
86082
Hom.:
0
Cov.:
0
AF XY:
0.0264
AC XY:
1163
AN XY:
44004
show subpopulations
Gnomad4 AFR exome
AF:
0.0238
Gnomad4 AMR exome
AF:
0.0272
Gnomad4 ASJ exome
AF:
0.0252
Gnomad4 EAS exome
AF:
0.0249
Gnomad4 SAS exome
AF:
0.0228
Gnomad4 FIN exome
AF:
0.0277
Gnomad4 NFE exome
AF:
0.0267
Gnomad4 OTH exome
AF:
0.0242
GnomAD4 genome
AF:
0.00125
AC:
180
AN:
143948
Hom.:
0
Cov.:
31
AF XY:
0.00112
AC XY:
78
AN XY:
69922
show subpopulations
Gnomad4 AFR
AF:
0.00281
Gnomad4 AMR
AF:
0.00131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00186
Gnomad4 SAS
AF:
0.000664
Gnomad4 FIN
AF:
0.000688
Gnomad4 NFE
AF:
0.000428
Gnomad4 OTH
AF:
0.00199

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Cortical dysplasia-focal epilepsy syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Pitt-Hopkins-like syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs886062041; hg19: chr7-145813627; API